Terremoto Biosciences
Develops highly targeted, small molecule medicines for cancer and rare diseases
$108MSeries C
Role not disclosedLoading investors…
Activity from announced rounds
Develops highly targeted, small molecule medicines for cancer and rare diseases
Develops first- and best-in-class antibody-drug conjugates (ADCs) for cancer treatment
Pitching Novo Holdings? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room